MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / Sponsored Content / Silicone Materials for Long-term Medical Implants: Innovate for the Future

Silicone Materials for Long-term Medical Implants: Innovate for the Future

June 4, 2019 By MassDevice Leave a Comment

medical implants

By Feifei Lin, Ph.D., Business Development Manager, Healthcare, Elkem Silicones USA Corp.

With the growth of the aging population, the number of age-related diseases has increased. Every year millions of patients sustained or improved their lives through surgical procedures involving implanted devices. Medical implants such as orthopedics, pacemakers, cardiovascular stents, defibrillators, neural prosthetics or combinational devices like drug-eluting stents have become an indispensable part of modern medicine.

Long-term implantable devices used to improve and sustain life are highly regulated by regulatory bodies around the world to ensure safety and efficacy. Raw materials supplied to medical implants are subjected to the qualification of the devices makers.

Silicone elastomer advantages

Primarily due to the stability of the Si-O-Si bond, silicone elastomers are more suitable for medical implants than carbon-based plastics and rubber in many aspects:

  • Unsurpassed biocompatibility and hypoallergenic
  • Chemically inert, resistant to oil, solvent and stain
  • Bacterial resistant, easy to clean and sterilize
  • Long shelf life, maintain performance and integrity under harsh conditions, such as -80C to 300C
  • Dielectric with superior insulating properties

Because silicone elastomers have these superior characteristics, silicones have been used in long-term implants for decades. The first published report of silicone elastomer for long term implantation was in 1946 by Dr. Franklin H Lahey, for bile duct repair[1].  By the late 1960s, the medical-grade silicone elastomer had found its way into many long-term implants such as joint arthroplasty, catheters, drains, and hydrocephalus shunts. For over half a century, silicone elastomers have proven to be a safe material that enables millions of patients to overcome debilitating conditions.

Today, as the market demands more efficient and effective care, long-term implantable devices are undergoing dramatic transformations due to advancement in the tech industry. The implants are becoming valuable biomedical control units for monitoring and responding on demand via wireless communication. Devices are getting smaller and are being integrated into electronics which require higher material performance to meet the requirements for integrity and durability; the integration of devices with Internet of Things (IOT) requires lower temperature fabrication.

With the future in mind, Elkem Silicones offers full lines of high-performance Silbione® Biomedical LSRs Silbione® Biomedical HCRs for LTI and drug delivery to meet the challenges of the industry. These offerings are based on the platinum-addition cure system and offer a full range of low to high durometer, higher physical properties, lot-to-lot consistency, and easy mold release.

Elkem Silicones has made significant investment in our manufacturing facility, quality system, and regulatory support to ensure we meet or exceed the standard for long-term implantable materials. Our state-of-the-art manufacturing site in York, SC is ISO 9001 certified with a certified ISO class 8 manufacturing environment and an ISO class 7 packaging environment. Material attestations, toxicology summaries, biocompatibility, MAF and DMF, are available upon request. Our on-staff toxicologists are available to provide regulatory support for these materials.

Elkem Silicones is advancing a robust innovation portfolio, covering high-performance silicone materials and process technologies that enable the future medical devices. In the upcoming MDM Minneapolis, Elkem Silicones will be launching a long term implantable grade, high performance, one-part, tin-free, ambient cure adhesive. This adhesive can bond to different surfaces such as silicone elastomers, polyurethane, polyester, aluminum, and titanium, etc. It offers significant productivity improvement and simplification in the manufacturing process because of fast cure without the need for heating and humidity. It is the first tin-free long-term implantable silicone adhesive in the market.

We have successfully demonstrated 3D printing with our LSRs, which not only enables rapid prototyping but also introduces the possibility of enhancing device physical properties through design. Unlike conventional injection molding, 3D printing LSRs makes it possible to print hollow scaffolds to increase elasticity, strength and decrease weight per part. Recently, Elkem Silicones launched the next generation LSR (liquid silicone rubber), LSR SELECT™, a patented, advanced system of LSR materials and dosing capabilities. This proven system gives you CONTROL to optimize your cure kinetics improving productivity and flexibility to achieve your precise results. In addition to controlling your cure profile, now you can create a repeatable, unique durometer blend. With this technology it is possible to over mold onto temperature sensitive components such as sensors or substrates, meeting the challenges of manufacture combinational drug delivery devices with heat sensitive active pharmaceutical ingredients.

Elkem is proud to be part of the long-term implantable material suppliers. Not only do we offer these materials, but also innovative solutions, expertise, and services to device makers, designers and fabricators. Together with our customers, we advance current and future implants to save people and better human lives.

Visit Elkem Silicones website for more product information. (https://silicones.elkem.com/EN/Our_offer/Market_And_Application/Pages/Long-term-medical-implants.aspx)

Contact Feifei.lin@elkem.com for further questions

LINKS:

LSR: https://resources.silicones.elkem.com/asset/29:elkemsiliconeslsrltilinecardna2018
HCR: https://resources.silicones.elkem.com/asset/28:elkemsiliconeshcrltilinecardnajune2018

[1] Biomaterial Science, An introduction to Materials in Medicine, by ELSEVIER ACADEMIC PRESS, 2nd edition, Chapter 7.19, p. 698, “Medical Application of Silicones”, Andre Colas and Jim Curtis

Sponsored content by Elkem Silicones

Filed Under: Sponsored Content Tagged With: elkemsilicones

In case you missed it

  • Bio-Rad recovering from ransomware attack
  • FDA clears first single-use duodenoscope from Boston Sci
  • FDA approves Tandem Diabetes’ advanced hybrid closed-loop controller
  • Awak Technologies raises $40m
  • Axonics raises additional $17m in public offering
  • Siemens Healthineers lands FDA clearance for two CT systems
  • Aethlon prices $5m offering
  • Sterigenics’ legal troubles mount in Illinois
  • In2Bones launches AlloAid BioNail
  • Caresyntax to acquire Syus; raises $45.6m
  • Nihon Kohden launches new patient monitor
  • Senate confirms Dr. Stephen Hahn to lead FDA
  • Iradimed renews CE mark for MRI-safe patient monitor
  • Flexicare recalls fiber optic laryngoscope blades and handles
  • 3M to sell drug-delivery biz to Altaris Capital Partners for $650m
  • TransEnterix announces reverse split of common stock
  • GI Windows raises $15m Series A

RSS From Medical Design & Outsourcing

  • Siemens Healthineers lands FDA clearance for two CT systems
    Siemens Healthineers this week said it won FDA clearance for its Somatom go.Sim and Somtom go.Open Pro computed tomography systems. The CT systems are designed for radiation therapy planning and are members of the company’s Somatom go. platform of devices. Siemens Healthineers’ platform uses hardware and software components like patient marking lasers and automated quality… […]
  • Protolabs’ healthcare grant spurs 2 feeding tube inventions
    Digital manufacturer Protolabs (NYSE:PRLB) announced today that MedStar Health (Columbia, Md.) and Cleveland Clinic Innovations are joint winners of the company’s Cool Idea Award: Healthcare Grant. These grants provide in-kind manufacturing services to the support development of medical products to spur innovation in the field. MedStar Health’s gravity-feed syringe holder simplifies the feeding of newborns who spend […]
  • Sterigenics’ legal troubles mount in Illinois
    Nearly two dozen new lawsuits were filed against Sterigenics this week over its now-shuttered ethylene oxide (EtO) sterilization plant in Willowbrook, Ill., according to a law firm representing some of the plaintiffs. That brings the total of such lawsuits to nearly 75, noted Chicago personal injury lawyer Antonio Romanucci, court-appointed lead counsel from among five… […]
  • In2Bones launches AlloAid BioNail
    In2Bones this week launched its AlloAid BioNail sterile allograft implant. The implant is designed to give rigid, stable fixation during hand and foot reconstruction. AlloAid BioNail is made from strong cortical allografts to provide osteoconductive properties for bone remodeling and healing. It features a tapered point and multiple, contoured wedge facets to ease insertion, anchor… […]
  • Protolabs’ healthcare grant spurs 2 feeding tube inventions
    Digital manufacturer Protolabs (NYSE:PRLB) announced today that MedStar Health (Columbia, Md.) and Cleveland Clinic Innovations are joint winners of the company’s Cool Idea Award: Healthcare Grant. These grants provide in-kind manufacturing services to the support development of medical products to spur innovation in the field. MedStar Health’s gravity-feed syringe holder simplifies the feeding of newborns… […]
  • Nihon Kohden launches new patient monitor
    Nihon Kohden (TYO:6849) announced the U.S. launch of its Life Scope SVM-7200 series vital signs monitor for outpatient facilities and beds that aren’t continuously monitored. The Life Scope SVM-7200 is designed to provide customizable early warning scoring to help clinicians identify patients who are deteriorating or at risk of deterioration. It combines vital signs data with… […]
  • Senate confirms Dr. Stephen Hahn to lead FDA
    The U.S. Senate has confirmed Dr. Stephen Hahn as the next commissioner of the FDA. The vote was 72 to 18, according to a report in the New York Times. Hahn will be the first permanent commissioner of the agency since Dr. Scott Gottlieb resigned in April. President Trump nominated Hahn, the chief medical officer at Houston’s… […]
  • 3M to sell drug-delivery biz to Altaris Capital Partners for $650m
    3M (NYSE:MMM) announced today that it entered into an agreement to sell most of its drug-delivery business to an affiliate of Altaris Capital Partners for approximately $650 million. St. Paul, Minn.-based 3M will retain its transdermal drug delivery components business, according to a news release. The business being divested has annual global sales reaching approximately… […]
  • Lawsuit endangers Sterigenics consent order in Georgia
    A consent order that Sterigenics entered into with the state of Georgia to reduce ethylene oxide (EtO) emissions at its Atlanta medtech sterilization plant may be in jeopardy. A hearing is scheduled today on a lawsuit that accuses the Georgia Environmental Protection Division (EPD) of failing to take public comment before entering the Aug. 7… […]
  • Trelleborg acquires Tritec Seal
    Trelleborg Sealing Solutions said today it has closed on its acquisition of rotary seal manufacturer Tritec Seal, which produces engineered polytetrafluoroethylene (PTFE) sealing solutions. Trelleborg said the acquisition strengthens its product portfolio while giving the business area access to increased manufacturing capacity. Headquartered in Fenton, Mich., with additional manufacturing in Giddings, Texas, Tritec Seal generated… […]
  • RSNA 2019: 7 radiology innovations you need to know
    Nearly 53,000 people attended the 2019 Radiological Society of North America annual meeting in Chicago last week. And they heard the same acronym over and over again: AI. Exhibitors at the conference touted their artificial-intelligence-enhanced technology at every turn, claiming to make images clearer, sharper, easier to use and powerful enough to help clinicians make… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS